30-Jan-2025 | D | Approved declaration of 3rd Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the FY 2024-25. The record date for the purpose of payment of 3 rd Interim Dividend shall be February 05, 2025.
The 3rd Interim Dividend will be dispatched/ credited within 30 days of the declaration. | 05-Feb-2025 | |
23-Oct-2024 | D | Board of Directors in their meeting held today i.e. October 23, 2024 interalia considered & approved the following(s):
Declaration of 2nd Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year 2024-25. The record date for the purpose of payment of 2nd Interim Dividend shall be November 5, 2024.
The 2nd Interim Dividend will be credited/ dispatched within 30 days of its declaration. | 05-Nov-2024 | |
07-Aug-2024 | D | Outcome of Board Meeting held on August 7, 2024
Declaration of Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year 2024-25. The record date for the purpose of payment of Interim Dividend shall be August 20, 2024. | 20-Aug-2024 | |
10-May-2024 | D | Recommendation of final dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year ended March 31, 2024 subject to approval of the Shareholders at ensuing Annual General Meeting ('AGM') of the Company. The record date for the purpose of payment of final dividend shall be June 10, 2024. | 10-Jun-2024 | |
01-Feb-2024 | D | Board of Directors in their meeting held today i.e. February 01, 2024, inter-alia, considered and approved the following:
Payment of 2nd Interim Dividend of INR 12/- per equity share (@ 120% on a face value of INR 10/- per share) for the FY 2023-24. The record date for the purpose of payment of 2nd Interim Dividend shall be February 13, 2024. | 13-Feb-2024 | |
11-May-2023 | D | Please take note that the Board of Directors in their meeting held today i.e. May 11, 2023 inter-alia approved the following(s): 1. Recommendation of final dividend of Rs. 6/- per equity share (@ 60% on a face value of Rs. 10/- per share) for the year ended March 31, 2023 subject to approval of the Shareholders at the forthcoming Annual General Meeting ('AGM') of the Company. Information regarding record date for payment of final dividend, if any, will be intimated in due course; | 11-Aug-2023 | |
28-Jul-2023 | D | Board of Directors in their meeting on July 27, 2023 approved payment of Interim Dividend INR 6/- per equity shares for FY 2023-24
| 11-Aug-2023 | |
28-Jul-2022 | D | Please take note that the Board of Directors in their meeting held today i.e. July 28, 2022 approved Unaudited Financial Results (Standalone and Consolidated) of the Company for the first quarter ended June 30, 2022.
At the said Meeting, the Board of Directors have also declared an interim dividend of Rs. 6/-per equity share (i.e. 60% on a face value of Rs. 10/- per share) for the FY 2022- 23. | 05-Aug-2022 | |
17-May-2022 | D | Please take note that the Board of Directors in their meeting held today i.e. May 17, 2022 Recommendation of final dividend of Rs.6/- per equity share (@ 60% on a face value of Rs.10/- per share) for the year ended March 31, 2022. The dividend, if approved by the shareholders at the ensuing Annual General Meeting (AGM) will be dispatched/ credited within 30 days of the AGM. | 22-Jun-2022 | |
30-Jul-2021 | D | Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 30, 2021, inter alia, have declared an interim dividend of Rs. 6/- per equity share (i.e. 60% on a face value of Rs. 10/- per share) for the Financial Year 2021- 22. | 18-Aug-2021 | |
21-May-2021 | D | Outcome Of Board Meeting Held On May 21, 2021
Recommendation of final dividend of Rs. 8 /- per equity share (@ 80 % on a face value of Rs. 10/- per share) for the year ended March 31, 2021. The dividend, if approved by the shareholders at the ensuing Annual General Meeting (AGM) will be dispatched/ credited within 30 days of the AGM. | 20-Jul-2021 | |
29-Jan-2021 | D | Please take note that the Board of Directors in their meeting held today i.e. January 29, 2021 approved Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2020.
A copy of the Results along with Limited Review Report issued by the Statutory Auditors M/s Deloitte Haskins & Sells, LLP on such financials for the Quarter and Nine Months ended December 31, 2020 is attached herewith.
At the said Meeting, the Board of Directors have also declared 2nd Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- per share) for the Financial Year 2020-21.
Also, kindly take note that the Board has fixed February 10, 2021 as the record date for the purpose of payment of interim dividend. The interim dividend will be paid by the Company on or before February 27, 2021.
The Board Meeting commenced at 1:30 P.M and concluded at 3:45 P.M.
We request you to please take the same on record. | 09-Feb-2021 | |
06-Nov-2020 | D | The Board of Directors have also declared an interim dividend of Rs. 6 /- per equity share (@ 60% on a face value of Rs. 10/- per share) for the Financial Year 2020-21. | 18-Nov-2020 | |
25-Feb-2020 | D | Please take note that the Board of Directors in their meeting held today i.e. February 25, 2020 declared 2nd Interim Dividend of Rs. 6/- per equity share (@ 60 % on a face value of Rs. 10/- per share) for the Financial Year 2019-20.
Also, kindly take note that the Board has fixed March 6, 2020 as the Record Date for the purpose of payment of 2nd Interim Dividend. The 2nd Interim Dividend will be paid by the Company on or after March 13, 2020.
The Board Meeting commenced at 3:30 PM and concluded at 4:25 PM.
We request you to please take the same on record. | 05-Mar-2020 | |
08-Nov-2019 | D | Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 08, 2019, inter alia, have declared an interim dividend of Rs. 6/- per equity share (@ 60% on a face value of Rs. 10/- per share) for the Financial Year 2019-20.
Further, the interim dividend will be paid by the Company on or after November 30, 2019. | 20-Nov-2019 | |
17-May-2019 | D | Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 17, 2019, inter alia, has recommendation of final dividend of Rs. 3.5/- per equity share (@ 35% on a face value of Rs. 10/- per share) for the year ended March 31, 2019. The dividend, if approved by the shareholders at the ensuing Annual General Meeting (AGM) will be paid on or after August 21, 2019. | 02-Aug-2019 | |
05-Nov-2018 | D | The Board of Directors in their meeting held today i.e. November 6, 2018 declared an interim dividend of Rs. 2.50 per equity share (@ 25 % on a face value of Rs. 10/- per share) for the Financial Year 2018-19. | 19-Nov-2018 | |
14-May-2018 | D | Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2018, inter alia, has recommended a dividend of Rs. 3/- per equity share (@ 30 % on a face value of Rs. 10/- per share) for the year ended March 31, 2018.
The dividend, if approved by the shareholders at the ensuing Annual General Meeting (AGM) will be paid on or after August 30, 2018. | 03-Aug-2018 | |
09-Nov-2017 | D | Please take note that the Board of Directors in their meeting held today i.e. November 9, 2017 approved the unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Half Year ended September 30, 2017.
At the said Meeting, the Board of Directors have also declared an interim dividend of Rs. 1.50 per equity share (@ 15 % on a face value of Rs. 10/- per share) for the Financial Year 2017-18.
Also, kindly take note that the Board has fixed November 21, 2017 as the record date for the purpose of payment of interim dividend. The interim dividend will be paid by the Company on or after December 4, 2017.
The Board Meeting commenced at 11:45 AM and concluded at 2 PM.
We request you to please take the same on record. | 20-Nov-2017 | |
10-May-2017 | D | Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2017, inter alia, has recommended a dividend of Rs. 1.70/- per equity share (@ 17 % on a face value of Rs. 10/- per share) for the year ended March 31, 2017. The dividend, if approved by the shareholders at the ensuing Annual General Meeting (AGM) will be paid on or after July 31, 2017. | 12-Jul-2017 | |
02-Feb-2017 | D | Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 02, 2017, inter alia, have declared an interim dividend of Rs. 1.30 per equity share (@ 13 % on a face value of Rs. 10/- per share) for the Financial Year 2016-17.
The interim dividend will be paid by the Company on or after February 21, 2017.
The Board Meeting commenced at 11:30 AM and concluded at 02:00 PM. | 13-Feb-2017 | |
27-May-2016 | D | Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, inter alia, have recommended a dividend of Rs. 2.45 per equity share (@ 24.5% on a face value of Rs. 10/- per share) for the year ended March 31, 2016. The dividend, if approved by the shareholders at the ensuing Annual General Meeting (AGM) will be paid on or after August 08, 2016.
The Board Meeting commenced at 11:15 AM and concluded at 2:00 PM. | 20-Jul-2016 | |
10-May-2024 | BC | Outcome of Board Meeting
Re-appointment of Dr. Vandana Lal (DIN: 00472955) as Whole-Time Director of the Company, for a period of Five (5) years commencing from April 01, 2025, subject to approval | 01-Apr-2025 | |
07-Aug-2024 | BC | Outcome of Board Meeting held on August 7, 2024
Declaration of Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year 2024-25. The record date | 31-Mar-2025 | |
23-Oct-2024 | BC | Board of Directors in their meeting held today i.e. October 23, 2024 interalia considered & approved the following(s):
Considered & took note that Dr. Om Prakash Manchanda (DIN: 02099404) will be | 31-Mar-2025 | |
23-Oct-2024 | BC | Board of Directors in their meeting held today i.e. October 23, 2024 interalia considered & approved the following(s):
Declaration of 2nd Interim Dividend of INR 6/- per equity share (@ 60% on a f | 31-Mar-2025 | |
30-Jan-2025 | BC | Approved declaration of 3rd Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the FY 2024-25. The record date for the purpose of payment of 3 rd Interim Divide | 31-Mar-2025 | |